Canada Life’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
22,069
+13,831
| +168% | +$160K | ﹤0.01% | 1688 |
|
|
2025
Q1 | $72K | Sell |
8,238
-19,670
| -70% | -$172K | ﹤0.01% | 1827 |
|
|
2024
Q4 | $400K | Sell |
27,908
-3,038
| -10% | -$43.5K | ﹤0.01% | 1677 |
|
|
2024
Q3 | $700K | Buy |
30,946
+164
| +0.5% | +$3.71K | ﹤0.01% | 1609 |
|
|
2024
Q2 | $599K | Buy |
30,782
+2,060
| +7% | +$40.1K | ﹤0.01% | 1640 |
|
|
2024
Q1 | $1.08M | Buy |
28,722
+241
| +0.8% | +$9.05K | ﹤0.01% | 1489 |
|
|
2023
Q4 | $1.58M | Buy |
28,481
+1,548
| +6% | +$86.1K | ﹤0.01% | 1349 |
|
|
2023
Q3 | $1.11M | Buy |
26,933
+5,437
| +25% | +$224K | ﹤0.01% | 1447 |
|
|
2023
Q2 | $1.21M | Buy |
21,496
+2,568
| +14% | +$144K | ﹤0.01% | 1436 |
|
|
2023
Q1 | $1.06M | Sell |
18,928
-246
| -1% | -$13.8K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $703K | Buy |
19,174
+6,817
| +55% | +$250K | ﹤0.01% | 1629 |
|
|
2022
Q3 | $351K | Buy |
12,357
+8,066
| +188% | +$229K | ﹤0.01% | 1756 |
|
|
2022
Q2 | $195K | Sell |
4,291
-58,343
| -93% | -$2.65M | ﹤0.01% | 1821 |
|
|
2022
Q1 | $5.04M | Buy |
62,634
+2,165
| +4% | +$174K | 0.01% | 758 |
|
|
2021
Q4 | $8.99M | Buy |
60,469
+18,667
| +45% | +$2.77M | 0.02% | 617 |
|
|
2021
Q3 | $6.13M | Buy |
41,802
+18,517
| +80% | +$2.71M | 0.01% | 674 |
|
|
2021
Q2 | $4.56M | Buy |
23,285
+3,994
| +21% | +$782K | 0.01% | 744 |
|
|
2021
Q1 | $3.47M | Buy |
19,291
+1,336
| +7% | +$240K | 0.01% | 827 |
|
|
2020
Q4 | $2.54M | Buy |
+17,955
| New | +$2.54M | ﹤0.01% | 1017 |
|